Intermittent dosing with sunitinib (Pf-02783926) and...

Bone 2012 Vol. 50; Iss. supp-S1

Intermittent dosing with sunitinib (Pf-02783926) and docetaxel provides effective therapy against lytic bone metastasis of human breast cancer

C.M. Bagi⁎, E. Berryman, C.J. Andresen
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
50
Year:
2012
Language:
english
Pages:
1
DOI:
10.1016/j.bone.2012.02.573
File:
PDF, 79 KB
english, 2012
Conversion to is in progress
Conversion to is failed